Anebulo Pharmaceuticals (ANEB) Amortization of Deferred Charges (2024 - 2025)
Anebulo Pharmaceuticals (ANEB) posted quarterly Amortization of Deferred Charges of $17439.0 for Q4 2025, down 70.79% year-over-year from $59696.0 in Q4 2024, and little changed quarter-over-quarter from $17440.0 in Q3 2025.
Anebulo Pharmaceuticals (ANEB) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Amortization of Deferred Charges for 2 consecutive years, with $17439.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Amortization of Deferred Charges fell 70.79% year-over-year to $17439.0; the TTM figure through Dec 2025 stood at $297500.0 (up 24.59% YoY), while the FY2025 annual figure was $382014.0, up 152.6% from the prior year.
- Amortization of Deferred Charges held at $17439.0 in Q4 2025 per ANEB's latest filing, from $17440.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $245182.0 in Q1 2025 and bottomed at $17439.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,439.00 |
| Dec 31, 2025 | 17,439.00 |
| Sep 30, 2025 | 17,440.00 |
| Sep 30, 2025 | 17,440.00 |
| Jun 30, 2025 | 17,439.00 |
| Jun 30, 2025 | 17,439.00 |
| Mar 31, 2025 | 245,182.00 |
| Mar 31, 2025 | 245,182.00 |
| Dec 31, 2024 | 59,696.00 |
| Dec 31, 2024 | 59,696.00 |
| Sep 30, 2024 | 59,697.00 |
| Sep 30, 2024 | 59,697.00 |
| Jun 30, 2024 | 59,696.00 |
| Jun 30, 2024 | 59,696.00 |
| Mar 31, 2024 | 59,696.00 |
| Mar 31, 2024 | 59,696.00 |